Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Our site is under planned maintenance. At this time, you will not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

eBriefing

Therapeutic Advances in Cancer Metabolism and Signaling

Therapeutic Advances in Cancer Metabolism and Signaling
Reported by
Kari Fischer

Posted July 31, 2020

Presented By

Cancer Discussion Group

The New York Academy of Sciences

The observation that cancer cells often have fundamentally different metabolic activities than their normal counterparts has led to resurgent interest in the field of cancer metabolism, and the designation of altered metabolism as a hallmark of cancer. Evidence suggests that cancer cells can leverage metabolic pathways to enhance survival, fuel proliferation, and even promote migration and distant metastatic colonization. Moreover, metabolites can act as signals or inhibitors that directly regulate chromatin-modifying enzymes, thereby influencing cell fate decisions that can be critical for cancer progression. These findings collectively suggest that targeting metabolic pathways provides new therapeutic strategies for the treatment of various cancer types. However, several of the metabolic alterations evident in cancer cells are also present in highly proliferative healthy cells, complicating attempts to safely and specifically target cancer cells. Therefore, it is critical to understand metabolic abnormalities in cancer, how oncogenic drivers trigger such changes, and whether metabolic differences represent viable targets for therapy.

The annual Cancer Metabolism and Signaling conference, held virtually on April 17, 2020, convened experts to discuss the defining features of cancer cell metabolism, and metabolic regulation in tumor progression and metastasis.

In this eBriefing, You’ll Learn:

  • Advances in the understanding of iron metabolism and cancer progression
  • The latest findings on the role of autophagy in cancer metabolism
  • How metabolism affects T Cell responses in cancer
  • Potential metabolic targets in cancer metastasis
Fendt/Pagliarini
Perera/Possemato
White/Boire
Blenis/Jones
Keynote/Q&A